Home
MENU
  • News
  • Legal Eubdate
  • Seminars
  • COVID-19
  • CSR
  • Contact
  • en
  • nl
  • fr
  • Home
  • Attorneys
  • Expertise
    • Banking & finance
    • Capital markets & listed entities
    • Commercial law & consumer protection
    • Competition
    • Corporate and M&A
    • Criminal enforcement & compliance
    • Digital & data protection
    • Dispute resolution & litigation
    • Employment
    • Energy
    • Estate planning & family businesses
    • Healthcare
    • Intellectual property
    • Liability & insurance
    • Life sciences
    • Mobility
    • Pensions
    • Public & administrative law
    • Public-private partnership
    • Real estate
    • Restructuring & insolvency
    • State-owned enterprises
    • Tax
  • Working at Eubelius
  • About Eubelius
  • Home
  • Attorneys
  • Odile Watté

Odile Watté

Attorney
+32 2 543 35 53 odile.watte@eubelius.com Download vCard

Expertises

Corporate and M&A

Languages

Dutch
English
French

Odile practices corporate law and M&A.

She joined Eubelius in 2019 and became a member of the Brussels Bar the same year.

View more
View less

Odile holds a law degree from the Vrije Universiteit Brussel (2019).

News
5 February 2021

Eubelius assists V-Bio Ventures with the launch of its second fund, V-Bio Fund 2, at €78 million

V-Bio Ventures is an independent venture capital firm that specialises in building and financing young, innovative life science companies.

Home
  • Home
  • Attorneys
  • Expertise
  • Working at Eubelius
  • About Eubelius
  • News
  • Legal Eubdate
  • Seminars
  • COVID-19
  • CSR
  • Contact
  • © Eubelius 2021 - All rights reserved
  • Legal information
  • Terms of use
  • Privacy policy
  • Cookies
https://nl.linkedin.com/company/eubelius
https://www.facebook.com/eubelius/
https://www.instagram.com/eubelius_law/
https://twitter.com/eubeliuslaw
https://vimeo.com/eubelius
Close
  • en
  • nl
  • fr
  • Home
  • Attorneys
  • Expertise
  • Working at Eubelius
  • About Eubelius
  • News
  • Legal Eubdate
  • Seminars
  • COVID-19
  • CSR
  • Contact
All content on our website, including the printed version thereof, is subject to the Terms of Use available on the website.